Conference and workshop papers
Michal Rosen-Zvi, Eugen Schülter, Andre Altman, Saleta Sierra-Aragon, Maurizio Zazzi, Andres Sönnerborg, Thomas Lengauer and Rolf Kaiser. Sustaining 3TC/FTC, ABC, AZT or ATV from a previous treatment shows a clinical benefit. "international hiv drug resistance workshop". April 2008.Michal Rosen-Zvi, Andre Altman, Mattia Prosperi, Ehud Aharoni, Hani Neuvirth-Telem, Andres Sonnerborg, Daniel Struk, Yardena Peres, Francesca Incardona, Rolf Kaiser, Mauirzio Zazzi and Thomas Lengauer. Selecting anti-HIV therapies based on a variety of genomic and clinical factors. International Conference Intelligent Systems for Molecular Biology - ISMB 2008. March 2008.